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Abstract
Background and objectives: Guillain-Barre syndrome during pregnancy is considered a rare 
neurological complication, and there is no consensus in literature for anesthetic management for 
cesarean section in such patients. The objective of this paper is to report the case of a pregnant 
woman with Guillain-Barre syndrome undergoing cesarean section. 
Case Report: Female patient, 22-year old, 35 weeks and 5 days of gestation, undergoing cesarean 
section, hospitalized, reporting decreased strength and lower limb paresthesias. Cerebrospinal 
ﬂ uid (CSF) analysis showed increased protein (304 mg.dL-1) without increased cellularity. The 
anesthetic technique used was general anesthesia induced with propofol (1.5 mg.kg-1) and 
maintained with 2% sevoﬂ urane in oxygen and fentanyl (3 μg.kg-1). The procedure was uneventful 
for both mother and neonate. The patient was discharged 10 days after admission, after progressive 
improvement of neurological symptoms.
Conclusion: The anesthetic technique for pregnant women with Guillain-Barre syndrome requiring 
cesarean section remains at the discretion of the anesthesiologist, who should be guided by the 
clinical conditions and comorbidities of each patient.
© 2013 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. 
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Introduction
Guillain-Barre syndrome (GBS) is an acute inﬂ ammatory 
demyelinating polyneuropathy characterized by progressive 
loss of strength, areﬂ exia and ascending ﬂ accid paralysis 1-4. 
GBS diagnosis is based on clinical presentation, laboratory 
tests, and electromyography. The anesthetic management 
for cesarean section in patients with GBS has no consensus 
in the literature, a fact that motivated this case report.
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Case report
Female, white, 22-year old, smoker, obese, with 35 weeks 
and 5 days gestation, previous history of urinary tract in-
fection, admitted to the hospital complaining of decreased 
strength in the lower limbs, which caused her fall from height 
three days before admission.
The patient reported lower limb paresthesias. Neurological 
examination revealed bilateral areﬂ exia, abolished plantar 
cutaneous reﬂ ex, and loss of strength in both legs. Brain and 
spinal magnetic resonance imaging was inconclusive. CSF 
analysis showed a clear, colorless liquid, with glucose level 
of 69 mg.dL-1 (45-80 mg.dL-1), protein of 304 mg.dL-1 (15-50 
mg.dL-1), and absence of changes in biochemistry or related 
to cellularity. Laboratory tests showed no hematological, 
biochemical, or coagulation changes. Obstetric examination 
revealed oligohydramnios, no history of vaginal loss, fetal 
heart rate unchanged, and prodromal labor.
GBS was diagnosed during neurological investigation 
and cesarean delivery indicated pregnancy termination. We 
initiated prophylaxis for thromboembolic events with subcu-
taneous low molecular weight heparin (40 mg).
The patient was monitored with electrocardiogram (DII 
and V5), peripheral oxygen saturation (SpO2), and noninvasive 
blood pressure. After venipuncture with an 18G intravenous 
device, 0.9% saline solution (10 mL.kg-1 body weight) was 
infused before induction of anesthesia.
We chose general anesthesia for the procedure. After 
pre-oxygenation, we administered propofol (1.5 mg.kg-1) 
and fentanyl (3 μg.kg-1.). Airway management was perfor-
med uneventfully with rapid sequence intubation, Sellick’s 
maneuver, and cannula with internal diameter in 7.0 mm.
After removal of the fetus and umbilical cord clamping, 
sevoﬂ urane 2% was initiated with intravenous supplementa-
tion of fentanyl (2 μg.kg-1). Intravenous dipyrone (50 mg.kg-1), 
ketoprofen (100 mg) cefazolin (2 g), and oxytocin (15 IU) 
diluted in 1,000 mL of 0.9% saline solution were also admi-
nistered. The patient was hemodynamically stable during 
the procedure and required no vasoactive drugs, resuming 
spontaneous ventilation, with volume and respiratory rate 
appropriate at the end of the procedure. Extubation was 
performed with the patient awake and cooperative, without 
problems.
The child showed no abnormalities at birth, with Apgar 
score of 8 at 1 minute and 10 at 5 minutes.
After surgery, the patient was taken to the post-anesthe-
sia recovery room on oxygen via nasal cannula (2 L.min-1), 
with 100% SpO2 and blood pressure within normal limits. 
There were no changes regarding preoperative clinical neu-
rological condition.
The patient was admitted to the neurology ward, sho-
wing a progressive improvement of GBS symptoms and was 
discharged after 10 days of hospitalization.
Discussion
GBS in pregnant population has an incidence similar to that 
of the general population of 1.7/100,000 per year. However, 
it is considered a serious event due to the complications that 
may affect both mother and fetus 5,6.
Although it is most often preceded by an infectious viral 
condition, in the case presented here the onset was insidious 
following an episode of urinary tract bacterial infection 
adequately treated with antibiotic therapy, differentiating 
it from epidemiological studies 4.
The suspected diagnosis in this case was conﬁ rmed by 
CSF analysis, which showed dissociation between protein 
level and CSF cytology 7. Electromyography was not per-
formed because the diagnosis had been conﬁ rmed by other 
methods.
Treatment of pregnant or nonpregnant patients with GBS 
is predominantly symptomatic. In nonpregnant women, plas-
mapheresis or immunoglobulin therapy accelerates recovery 7. 
Although described in the literature, the use of these therapies 
in pregnant women does not yet provide an adequate level of 
evidence to be indicated in this case.
The obstetric management of pregnant women with 
GBS is not different from that of other pregnant women, 
as uterine dynamics is maintained and vaginal delivery can 
be uneventfully performed 8. The indication for pregnancy 
termination by the obstetric team through cesarean delivery 
occurred due to the presence of neurological disease.
There has been no consensus in literature over the anes-
thetic technique for cesarean section in the presence of a GBS 
episode. Regional anesthesia (epidural or subarachnoid) and 
general anesthesia are techniques used by various authors.
The choice of the analgesic technique and anesthesia 
for cesarean section in pregnant women with GBS should be 
carefully evaluated because both are potentially high risk 
in this population 1.
The potential risk of regional anesthesia in patients with 
neurological diseases should not be underestimated. Steiner 
et al. reported the occurrence of GBS one to two weeks af-
ter epidural anesthesia in two patients undergoing general 
surgery and on one patient undergoing cesarean section 9. A 
causal relationship between the anesthesia performed in the-
se patients and GBS cannot be established, as other reports 
have shown the development of GBS in patients undergoing 
surgical procedures under general anesthesia.
Particularly in the pregnant population with GBS, the 
epidural anesthesia or spinal block for both labor and 
cesarean section analgesia was uneventful with good tole-
rability by the patients, as reported by Brooks et al.  8 and 
MacGrady 10.
However, patients with GBS have greater sensitivity to 
local anesthetics, which may cause a spread of sympathetic 
block greater than expected, with unexpected hemodynamic 
effects (hypotension, bradycardia, and cardiovascular system 
collapse) 11. Brooks et al. suggest the cautious administration 
of local anesthetic through an epidural catheter to establish 
the desired level of blockade for cesarean section in patients 
with GBS and the use of direct-acting sympathomimetic 
agents to correct hypotension, as the indirect-acting drug 
response is unpredictable in these cases 8.
The most prevalent non-anesthetic complication in 
pregnant women with GBS is pulmonary thromboembolism, 
which leads to high maternal mortality. Prophylaxis with low 
molecular weight heparin is an emergency procedure and 
was appropriately adopted in this case 5,6.
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We chose general anesthesia based on the patient’s clini-
cal condition and use of low molecular weight heparin, as the 
worsening of neurological symptoms during the perioperative 
period would hinder further evaluation if there were any 
complications related to regional anesthesia.
The patient presented physiological changes related to 
pregnancy, including difﬁ cult airway management 12. Even 
taking precautionary measures relating to fasting, induction 
of anesthesia was performed considering the patient on a 
full stomach. In the clinical assessment, the patient airway 
had no predictive factors of difﬁ cult airway.
Airway was managed uneventfully with Sellick’s maneu-
ver. Although very controversial, avoiding neuromuscular 
blocking drugs during intubation was taken into account 
regarding GBS.
The depolarizing neuromuscular blocker succinylcholine 
would be the drug of choice for rapid sequence airway mana-
gement, but the possibility of hyperkalemia with consequent 
cardiac arrest due to ﬂ accid muscle paralysis in this patient 
was a contraindication 13.
The use of non-depolarizing neuromuscular blocking 
agents in patients with GBS presents risk of prolonged blo-
ckade, requiring ventilatory support postoperatively. There 
is no basis in the literature for the use of sugammadex in 
patients with GBS 14.
The use of inhaled anesthetics has no clinical conse-
quences associated with GBS pathophysiology. However, its 
administration must take into account the possible autonomic 
changes that may accompany this disease in order to avoid 
hemodynamic effects in these patients 13.
Opioid analgesics have no interference in GBS patho-
physiology as well, but its use should be determined by the 
clinical condition of the mother and repercussions on the 
fetus.
In conclusion, the anesthetic technique to be used in 
pregnant patients with Guillain-Barre syndrome requiring 
cesarean section remains at the discretion of the anesthe-
siologist, who must be guided by the clinical condition and 
comorbidities of each patient.
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